{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:33:35Z","timestamp":1794652415216,"version":"4.9.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:00:00Z","timestamp":1662768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"GlaxoSmithKline"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although tuberculosis (TB) is a curable disease, treatment is complex and prolonged, requiring considerable commitment from patients. This study aimed to understand the common perspectives of TB patients across Brazil, Russia, India, China, and South Africa throughout their disease journey, including the emotional, psychological, and practical challenges that patients and their families face.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This qualitative market research study was conducted between July 2020 and February 2021. Eight TB patients from each country (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940) completed health questionnaires, video\/telephone interviews, and diaries regarding their experiences of TB. Additionally, 52 household members were interviewed. Patients at different stages of their TB treatment journey, from a range of socioeconomic groups, with or without TB risk factors were sought. Anonymized data underwent triangulation and thematic analysis by iterative coding of statements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sample included 23 men and 17 women aged 13\u201360\u00a0years old, with risk factors for TB reported by 23\/40 patients. Although patients were from different countries and cultural backgrounds, experiencing diverse health system contexts, five themes emerged as common across the sample. 1) Economic hardship from loss of income and medical\/travel expenses. 2) Widespread stigma, delaying presentation and deeply affecting patients\u2019 emotional wellbeing. 3) TB and HIV co-infection was particularly challenging, but increased TB awareness and accelerated diagnosis. 4) Disruption to family life strained relationships and increased patients\u2019 feelings of isolation and loneliness. 5) The COVID-19 pandemic made it easier for TB patients to keep their condition private, but disrupted access to services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite disparate cultural, socio-economic, and systemic contexts across countries, TB patients experience common challenges. A robust examination of the needs of individual patients and their families is required to improve the patient experience, encourage adherence, and promote cure, given the limitations of current treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-022-14115-7","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T20:02:27Z","timestamp":1662753747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Living with tuberculosis: a qualitative study of patients\u2019 experiences with disease and treatment"],"prefix":"10.1186","volume":"22","author":[{"given":"Juliet","family":"Addo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn","family":"Metcalf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Lundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barros-Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin C. K. W.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,10]]},"reference":[{"key":"14115_CR1","unstructured":"World Health Organization. Global tuberculosis report 2021. 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240037021. Accessed 1 Nov\u00a02021."},{"issue":"6","key":"14115_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.2471\/BLT.13.133116","volume":"92","author":"J Creswell","year":"2014","unstructured":"Creswell J, Sahu S, Sachdeva KS, Ditiu L, Barreira D, Mariandyshev A, Mingting C, Pillay Y. Tuberculosis in BRICS: challenges and opportunities for leadership within the post-2015 agenda. Bull World Health Organ. 2014;92(6):459\u201360.","journal-title":"Bull World Health Organ"},{"key":"14115_CR3","unstructured":"World Health Organization. Global tuberculosis report 2020. 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240013131. Accessed 1 Nov\u00a02021."},{"key":"14115_CR4","unstructured":"World Health Organization. The End TB Strategy: Global strategy and targets for tuberculosis prevention, care and control after 2015. 2014. https:\/\/www.who.int\/tb\/strategy\/End_TB_Strategy.pdf. Accessed 4 July 2021."},{"issue":"7","key":"14115_CR5","doi-asserted-by":"publisher","first-page":"723","DOI":"10.5588\/ijtld.17.0835","volume":"22","author":"K Floyd","year":"2018","unstructured":"Floyd K, Glaziou P, Houben R, Sumner T, White RG, Raviglione M. Global tuberculosis targets and milestones set for 2016\u20132035: definition and rationale. Int J Tuberc Lung Dis. 2018;22(7):723\u201330.","journal-title":"Int J Tuberc Lung Dis"},{"key":"14115_CR6","unstructured":"United Nations General Assembly. A\/RES\/73\/3. Political declaration of the high-level meeting of the General Assembly on the fight against tuberculosis. 2018. https:\/\/www.un.org\/en\/ga\/search\/view_doc.asp?symbol=A\/RES\/73\/3. Accessed 4 July 2021."},{"key":"14115_CR7","doi-asserted-by":"crossref","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment. 2020. https:\/\/www.who.int\/publications\/i\/item\/who-consolidated-guidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment. Accessed 4 July 2020.","DOI":"10.30978\/TB2021-2-86"},{"issue":"12","key":"14115_CR8","doi-asserted-by":"publisher","first-page":"e1272","DOI":"10.1016\/S2214-109X(18)30378-4","volume":"6","author":"PB Shete","year":"2018","unstructured":"Shete PB, Reid M, Goosby E. Message to world leaders: we cannot end tuberculosis without addressing the social and economic burden of the disease. Lancet Glob Health. 2018;6(12):e1272\u20133.","journal-title":"Lancet Glob Health"},{"issue":"6","key":"14115_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/2168479015580384","volume":"49","author":"A Hoos","year":"2015","unstructured":"Hoos A, Anderson J, Boutin M, Dewulf L, Geissler J, Johnston G, Joos A, Metcalf M, Regnante J, Sargeant I, et al. Partnering with patients in the development and lifecycle of medicines: A call for action. Ther Innov Regul Sci. 2015;49(6):929\u201339.","journal-title":"Ther Innov Regul Sci"},{"issue":"7","key":"14115_CR10","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/cid\/ciz1044","volume":"71","author":"MR Reichler","year":"2020","unstructured":"Reichler MR, Khan A, Yuan Y, Chen B, McAuley J, Mangura B, Sterling TR. Tuberculosis epidemiologic studies consortium task order team: Duration of exposure among close contacts of patients with infectious tuberculosis and risk of latent tuberculosis infection. Clin Infect Dis. 2020;71(7):1627\u201334.","journal-title":"Clin Infect Dis"},{"key":"14115_CR11","unstructured":"World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255052\/9789241550000-eng.pdf. Accessed 4 July 2021."},{"key":"14115_CR12","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment. 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240007048. Accessed 4 July 2021."},{"issue":"11","key":"14115_CR13","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.5588\/ijtld.14.0242","volume":"18","author":"S Hoger","year":"2014","unstructured":"Hoger S, Lykens K, Beavers SF, Katz D, Miller TL. Longevity loss among cured tuberculosis patients and the potential value of prevention. Int J Tuberc Lung Dis. 2014;18(11):1347\u201352.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"14115_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1159\/000512531","volume":"100","author":"BW Allwood","year":"2021","unstructured":"Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD. Post-tuberculosis lung disease: Clinical review of an under-recognised global challenge. Respiration. 2021;100(8):751\u201363.","journal-title":"Respiration"},{"issue":"3","key":"14115_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7196\/SAMJ.2019.v109i3.13366","volume":"109","author":"P Mkoko","year":"2019","unstructured":"Mkoko P, Naidoo S, Mbanga LC, Nomvete F, Muloiwa R, Dlamini S. Chronic lung disease and a history of tuberculosis (post-tuberculosis lung disease): Clinical features and in-hospital outcomes in a resource-limited setting with a high HIV burden. S Afr Med J. 2019;109(3):169\u201373.","journal-title":"S Afr Med J"},{"issue":"24","key":"14115_CR16","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.3390\/ijerph16244977","volume":"16","author":"H Matakanye","year":"2019","unstructured":"Matakanye H, Ramathuba DU, Tugli AK. Caring for tuberculosis patients: Understanding the plight of nurses at a regional hospital in Limpopo Province, South Africa. Int J Environ Res Public Health. 2019;16(24):4977.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"14115_CR17","doi-asserted-by":"publisher","DOI":"10.2196\/23294","volume":"23","author":"BE Thomas","year":"2021","unstructured":"Thomas BE, Kumar JV, Periyasamy M, Khandewale AS, Hephzibah Mercy J, Raj EM, Kokila S, Walgude AS, Gaurkhede GR, Kumbhar JD, et al. Acceptability of the medication event reminder monitor for promoting adherence to multidrug-resistant tuberculosis therapy in two Indian cities: Qualitative study of patients and health care providers. J Med Internet Res. 2021;23(6): e23294.","journal-title":"J Med Internet Res"},{"key":"14115_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2021.104421","volume":"149","author":"H Milligan","year":"2021","unstructured":"Milligan H, Iribarren SJ, Chirico C, Telles H, Schnall R. Insights from participant engagement with the tuberculosis treatment support tools intervention: Thematic analysis of interactive messages to guide refinement to better meet end user needs. Int J Med Inform. 2021;149: 104421.","journal-title":"Int J Med Inform"},{"key":"14115_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1186\/1471-2458-13-595","volume":"13","author":"AA Dias","year":"2013","unstructured":"Dias AA, de Oliveira DM, Turato ER, de Figueiredo RM. Life experiences of patients who have completed tuberculosis treatment: a qualitative investigation in southeast Brazil. BMC Public Health. 2013;13:595.","journal-title":"BMC Public Health"},{"issue":"1","key":"14115_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209924","volume":"14","author":"A Bhattacharya Chakravarty","year":"2019","unstructured":"Bhattacharya Chakravarty A, Rangan S, Dholakia Y, Rai S, Kamble S, Raste T, Shah S, Shah S, Mistry N. Such a long journey: What health seeking pathways of patients with drug resistant tuberculosis in Mumbai tell us. PLoS ONE. 2019;14(1): e0209924.","journal-title":"PLoS ONE"},{"issue":"Suppl 4","key":"14115_CR21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/00333549101250S407","volume":"125","author":"A Courtwright","year":"2010","unstructured":"Courtwright A, Turner AN. Tuberculosis and stigmatization: pathways and interventions. Public Health Rep. 2010;125(Suppl 4):34\u201342.","journal-title":"Public Health Rep"},{"key":"14115_CR22","unstructured":"The European Parliament and the Council of the European Union: Regulation (EU) 2016\/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95\/46\/EC (General Data Protection Regulation). Official Journal of the European Union.\u00a02016;L119:1-88."},{"key":"14115_CR23","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.2147\/IDR.S277203","volume":"13","author":"Q An","year":"2020","unstructured":"An Q, Song W, Liu J, Tao N, Liu Y, Zhang Q, Xu T, Li S, Liu S, Li Y, et al. Primary drug-resistance pattern and trend in elderly tuberculosis patients in Shandong, China, from 2004 to 2019. Infect Drug Resist. 2020;13:4133\u201345.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"14115_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.srhc.2013.04.004","volume":"4","author":"E Isman","year":"2013","unstructured":"Isman E, Ekeus C, Berggren V. Perceptions and experiences of female genital mutilation after immigration to Sweden: an explorative study. Sex Reprod Healthc. 2013;4(3):93\u20138.","journal-title":"Sex Reprod Healthc"},{"key":"14115_CR25","doi-asserted-by":"publisher","first-page":"785148","DOI":"10.1155\/2013\/785148","volume":"2013","author":"E Isman","year":"2013","unstructured":"Isman E, Mahmoud Warsame A, Johansson A, Fried S, Berggren V. Midwives\u2019 experiences in providing care and counselling to women with female genital mutilation (FGM) related problems. Obstet Gynecol Int. 2013;2013:785148.","journal-title":"Obstet Gynecol Int"},{"key":"14115_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods. 2006;18:59\u201382.","journal-title":"Field Methods"},{"key":"14115_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3:77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"14115_CR28","volume-title":"Qualitative methods for health research","author":"J Green","year":"2009","unstructured":"Green J, Thorogood N. Qualitative methods for health research. 2nd ed. London: Sage; 2009.","edition":"2"},{"issue":"3","key":"14115_CR29","doi-asserted-by":"publisher","DOI":"10.1590\/0034-7167-2019-0906","volume":"74","author":"FBA Aragao","year":"2021","unstructured":"Aragao FBA, Arcencio RA, Fuentealba-Torres M, Carneiro TSG, Souza LLL, Alves YM, Fiorati RC. Impact of social protection programs on adults diagnosed with tuberculosis: systematic review. Rev Bras Enferm. 2021;74(3): e20190906.","journal-title":"Rev Bras Enferm"},{"issue":"3","key":"14115_CR30","doi-asserted-by":"publisher","first-page":"110","DOI":"10.5588\/pha.20.0017","volume":"10","author":"P Sinha","year":"2020","unstructured":"Sinha P, Carwile M, Bhargava A, Cintron C, Acuna-Villaorduna C, Lakshminarayan S, Liu AF, Kulatilaka N, Locks L, Hochberg NS. How much do Indians pay for tuberculosis treatment? A cost analysis. Public Health Action. 2020;10(3):110\u20137.","journal-title":"Public Health Action"},{"issue":"1","key":"14115_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40249-019-0564-2","volume":"8","author":"CH Xu","year":"2019","unstructured":"Xu CH, Jeyashree K, Shewade HD, Xia YY, Wang LX, Liu Y, Zhang H, Wang L. Inequity in catastrophic costs among tuberculosis-affected households in China. Infect Dis Poverty. 2019;8(1):46.","journal-title":"Infect Dis Poverty"},{"issue":"6","key":"14115_CR32","doi-asserted-by":"publisher","first-page":"756","DOI":"10.5588\/ijtld.18.0519","volume":"23","author":"N Stracker","year":"2019","unstructured":"Stracker N, Hanrahan C, Mmolawa L, Nonyane B, Tampi R, Tucker A, West N, Lebina L, Martinson N, Dowdy D. Risk factors for catastrophic costs associated with tuberculosis in rural South Africa. Int J Tuberc Lung Dis. 2019;23(6):756\u201363.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"14115_CR33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1186\/s12889-020-09136-z","volume":"20","author":"T Yang","year":"2020","unstructured":"Yang T, Chen T, Che Y, Chen Q, Bo D. Factors associated with catastrophic total costs due to tuberculosis under a designated hospital service model: a cross-sectional study in China. BMC Public Health. 2020;20(1):1009.","journal-title":"BMC Public Health"},{"issue":"1","key":"14115_CR34","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1186\/s12913-020-05686-5","volume":"20","author":"L Lu","year":"2020","unstructured":"Lu L, Jiang Q, Hong J, Jin X, Gao Q, Bang H, DeRiemer K, Yang C. Catastrophic costs of tuberculosis care in a population with internal migrants in China. BMC Health Serv Res. 2020;20(1):832.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"14115_CR35","doi-asserted-by":"publisher","first-page":"e20200015","DOI":"10.36416\/1806-3756\/e20200015","volume":"46","author":"A Moreira","year":"2020","unstructured":"Moreira A, Kritski AL, Carvalho ACC. Social determinants of health and catastrophic costs associated with the diagnosis and treatment of tuberculosis. J Bras Pneumol. 2020;46(5):e20200015.","journal-title":"J Bras Pneumol"},{"issue":"1","key":"14115_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12889-017-4089-y","volume":"17","author":"C Hutchison","year":"2017","unstructured":"Hutchison C, Khan MS, Yoong J, Lin X, Coker RJ. Financial barriers and coping strategies: a qualitative study of accessing multidrug-resistant tuberculosis and tuberculosis care in Yunnan, China. BMC Public Health. 2017;17(1):221.","journal-title":"BMC Public Health"},{"issue":"12","key":"14115_CR37","doi-asserted-by":"publisher","first-page":"e033158","DOI":"10.1136\/bmjopen-2019-033158","volume":"9","author":"BH Patel","year":"2019","unstructured":"Patel BH, Jeyashree K, Chinnakali P, Vijayageetha M, Mehta KG, Modi B, Chavda PD, Dave PV, Zala CC, Shewade HD, et al. Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study. BMJ Open. 2019;9(12):e033158.","journal-title":"BMJ Open"},{"issue":"11","key":"14115_CR38","doi-asserted-by":"publisher","first-page":"e1002418","DOI":"10.1371\/journal.pmed.1002418","volume":"14","author":"WE Rudgard","year":"2017","unstructured":"Rudgard WE, Evans CA, Sweeney S, Wingfield T, Lonnroth K, Barreira D, Boccia D. Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study. PLoS Med. 2017;14(11):e1002418.","journal-title":"PLoS Med"},{"issue":"11","key":"14115_CR39","doi-asserted-by":"publisher","first-page":"e1123","DOI":"10.1016\/S2214-109X(17)30341-8","volume":"5","author":"S Verguet","year":"2017","unstructured":"Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben R, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, et al. Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study. Lancet Glob Health. 2017;5(11):e1123\u201332.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"14115_CR40","first-page":"1493","volume":"13","author":"SH Lu","year":"2009","unstructured":"Lu SH, Tian BC, Kang XP, Zhang W, Meng XP, Zhang JB, Lo SK. Public awareness of tuberculosis in China: a national survey of 69 253 subjects. Int J Tuberc Lung Dis. 2009;13(12):1493\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"14115_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijtb.2017.05.003","volume":"65","author":"RD Deshmukh","year":"2018","unstructured":"Deshmukh RD, Dhande DJ, Sachdeva KS, Sreenivas AN, Kumar AMV, Parmar M. Social support a key factor for adherence to multidrug-resistant tuberculosis treatment. Indian J Tuberc. 2018;65(1):41\u20137.","journal-title":"Indian J Tuberc"},{"issue":"3","key":"14115_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1017\/S0021932018000263","volume":"51","author":"O Zvonareva","year":"2019","unstructured":"Zvonareva O, van Bergen W, Kabanets N, Alliluyev A, Filinyuk O. Experiencing syndemic: Disentangling the biosocial complexity of tuberculosis through qualitative research. J Biosoc Sci. 2019;51(3):403\u201317.","journal-title":"J Biosoc Sci"},{"issue":"1","key":"14115_CR43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12879-021-06284-4","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Wu R, Xu J, Wang J, Gao M, Chen Y, Pan Y, Ji H, Duan Y, Sun M, et al. Prevalence and associated factors of psychological distress in tuberculosis patients in Northeast China: a cross-sectional study. BMC Infect Dis. 2021;21(1):563.","journal-title":"BMC Infect Dis"},{"issue":"23\u201324","key":"14115_CR44","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1111\/jocn.13837","volume":"26","author":"LY Lee","year":"2017","unstructured":"Lee LY, Tung HH, Chen SC, Fu CH. Perceived stigma and depression in initially diagnosed pulmonary tuberculosis patients. J Clin Nurs. 2017;26(23\u201324):4813\u201321.","journal-title":"J Clin Nurs"},{"issue":"1","key":"14115_CR45","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4269\/ajtmh.18-0324","volume":"100","author":"L Qiu","year":"2019","unstructured":"Qiu L, Tong Y, Lu Z, Gong Y, Yin X. Depressive symptoms mediate the associations of stigma with medication adherence and quality of life in tuberculosis patients in China. Am J Trop Med Hyg. 2019;100(1):31\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"14115_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12889-020-10055-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Du L, Wu R, Xu J, Ji H, Zhang Y, Zhu X, Zhou L. Tuberculosis-related stigma and its determinants in Dalian, Northeast China: a cross-sectional study. BMC Public Health. 2021;21(1):6.","journal-title":"BMC Public Health"},{"issue":"1","key":"14115_CR47","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/s12889-020-09150-1","volume":"20","author":"F Sathar","year":"2020","unstructured":"Sathar F, Velen K, Peterson M, Charalambous S, Chetty-Makkan CM. \u201cKnock\u201d: a qualitative study exploring the experience of household contacts on home visits and their attitude towards people living with TB in South Africa. BMC Public Health. 2020;20(1):1047.","journal-title":"BMC Public Health"},{"issue":"4","key":"14115_CR48","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.ijtb.2020.07.028","volume":"67","author":"M Rajalakshmi","year":"2020","unstructured":"Rajalakshmi M, Kalaiselvan G, Sudhakar R, Dhikale PT. An exploratory mixed method study on the follow up status and quality of life among recurrent tuberculosis patients in South India. Indian J Tuberc. 2020;67(4):515\u201322.","journal-title":"Indian J Tuberc"},{"issue":"10","key":"14115_CR49","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1097\/00002030-200007070-00015","volume":"14","author":"J Ngamvithayapong","year":"2000","unstructured":"Ngamvithayapong J, Winkvist A, Diwan V. High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area. Thailand AIDS. 2000;14(10):1413\u20139.","journal-title":"Thailand AIDS"},{"issue":"10","key":"14115_CR50","doi-asserted-by":"publisher","first-page":"e0230849","DOI":"10.1371\/journal.pone.0230849","volume":"15","author":"N Lince-Deroche","year":"2020","unstructured":"Lince-Deroche N, Leuner R, Kgowedi S, Moolla A, Madlala S, Manganye P, Xhosa B, Govathson C, White Ndwanya T, Long L. Voices from the front lines: A qualitative study of integration of HIV, tuberculosis, and primary healthcare services in Johannesburg, South Africa. PLoS ONE. 2020;15(10):e0230849.","journal-title":"PLoS ONE"},{"issue":"4","key":"14115_CR51","doi-asserted-by":"publisher","first-page":"e479","DOI":"10.1016\/S2214-109X(20)30548-9","volume":"9","author":"A Daftary","year":"2021","unstructured":"Daftary A, Mondal S, Zelnick J, Friedland G, Seepamore B, Boodhram R, Amico KR, Padayatchi N, O\u2019Donnell MR. Dynamic needs and challenges of people with drug-resistant tuberculosis and HIV in South Africa: a qualitative study. Lancet Glob Health. 2021;9(4):e479\u201388.","journal-title":"Lancet Glob Health"},{"issue":"9","key":"14115_CR52","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/17441692.2014.934266","volume":"9","author":"A Daftary","year":"2014","unstructured":"Daftary A, Padayatchi N, O\u2019Donnell M. Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB\/HIV co-infected patients in South Africa. Glob Public Health. 2014;9(9):1107\u201316.","journal-title":"Glob Public Health"},{"key":"14115_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113639","volume":"270","author":"J Daniels","year":"2021","unstructured":"Daniels J, Medina-Marino A, Glockner K, Grew E, Ngcelwane N, Kipp A. Masculinity, resources, and retention in care: South African men\u2019s behaviors and experiences while engaged in TB care and treatment. Soc Sci Med. 2021;270: 113639.","journal-title":"Soc Sci Med"},{"issue":"1","key":"14115_CR54","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1186\/s12889-017-4752-3","volume":"17","author":"RD da Silva","year":"2017","unstructured":"da Silva RD, de Luna FDT, de Araujo AJ, Camelo ELS, Bertolozzi MR, Hino P, Lacerda SNB, Fook SML, de Figueiredo T. Patients\u2019 perception regarding the influence of individual and social vulnerabilities on the adherence to tuberculosis treatment: a qualitative study. BMC Public Health. 2017;17(1):725.","journal-title":"BMC Public Health"},{"issue":"11","key":"14115_CR55","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.3201\/eid2611.203163","volume":"26","author":"GB Migliori","year":"2020","unstructured":"Migliori GB, Thong PM, Akkerman O, Alffenaar JW, Alvarez-Navascues F, Assao-Neino MM, Bernard PV, Biala JS, Blanc FX, Bogorodskaya EM, et al. Worldwide effects of coronavirus disease pandemic on tuberculosis services, January-April 2020. Emerg Infect Dis. 2020;26(11):2709\u201312.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"14115_CR56","doi-asserted-by":"publisher","first-page":"e0249822","DOI":"10.1371\/journal.pone.0249822","volume":"16","author":"FLD Santos","year":"2021","unstructured":"Santos FLD, Souza LLL, Bruce ATI, Crispim JA, Arroyo LH, Ramos ACV, Berra TZ, Alves YM, Scholze AR, Costa F, et al. Patients\u2019 perceptions regarding multidrug-resistant tuberculosis and barriers to seeking care in a priority city in Brazil during COVID-19 pandemic: A qualitative study. PLoS ONE. 2021;16(4):e0249822.","journal-title":"PLoS ONE"},{"issue":"12","key":"14115_CR57","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/23744235.2020.1806353","volume":"52","author":"KTL Sy","year":"2020","unstructured":"Sy KTL, Haw NJL, Uy J. Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond). 2020;52(12):902\u20137.","journal-title":"Infect Dis (Lond)"},{"issue":"2","key":"14115_CR58","first-page":"e2020128","volume":"29","author":"ELN Maciel","year":"2020","unstructured":"Maciel ELN, Goncalves Junior E, Dalcolmo MMP. Tuberculosis and coronavirus: what do we know? Epidemiol Serv Saude. 2020;29(2):e2020128.","journal-title":"Epidemiol Serv Saude"},{"issue":"3","key":"14115_CR59","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4081\/monaldi.2020.1368","volume":"90","author":"A Singh","year":"2020","unstructured":"Singh A, Prasad R, Gupta A, Das K, Gupta N. Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: convergence can be fatal. Monaldi Arch Chest Dis. 2020;90(3):441\u201350.","journal-title":"Monaldi Arch Chest Dis"},{"key":"14115_CR60","unstructured":"European Pharmaceutical Market Research Association. Code of Conduct 2020. 2020. https:\/\/www.ephmra.org\/media\/4857\/ephmra-2020-code-of-conduct-final.pdf. Accessed 8 Feb\u00a02022."},{"key":"14115_CR61","unstructured":"International Chamber of Commerce, European Society for Opinion and Marketing Research. ICC\/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics. 2016. https:\/\/esomar.org\/code-and-guidelines\/icc-esomar-code. Accessed 8 February 2022."},{"key":"14115_CR62","unstructured":"British Healthcare Business Intelligence Association. Legal and Ethical Guidelines for Healthcare Market Research: Your essential guide. 2021. https:\/\/www.bhbia.org.uk\/guidelines-and-legislation\/legal-and-ethical-guidelines. Accessed 8 Feb\u00a02022."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-14115-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-14115-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T20:03:00Z","timestamp":1662753780000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-14115-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,10]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14115"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-14115-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,10]]},"assertion":[{"value":"19 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted in accordance with the Helsinki Declaration, and all national data protection laws. In compliance with European Union and UK legislation, General Data Protection Regulation guidelines were followed to ensure full patient data confidentiality [\n                      \n                      ]. Informed consent was obtained electronically from all individual participants included in the study or their parents\/guardians if under the age of consent. Consent was also provided for anonymized consolidated publication of the findings. Participants\u2019 rights and privacy were protected at all times throughout the study. Participants were granted the right to withdraw from the study at any time during the study conduct and to withhold information as they saw fit. All information\/data that could identify respondents to third parties was kept strictly confidential; all respondents remained anonymous by using nicknames for the study.The study complied with international guidance on the conduct of market research, including the European Pharmaceutical Market Research Association (EphMRA) [\n                      \n                      ], the European Society for Opinion and Marketing Research (ESOMAR) [\n                      \n                      ], and the British Healthcare Business Intelligence Association (BHBIA) [\n                      \n                      ], and all other relevant national codes of conduct. Formal ethics approval was waived on the basis that only anonymised data were collected for market research purposes, without treatment intervention, the assessment of clinical endpoints, or the testing of any clinical hypothesis. Specifically, EphMRA defines market research as:\n                      \n                      Market Research is defined by the objective(s) and the approach, not by the title of the work or those involved in it. Consequently, the EphMRA Code of Conduct includes areas such as digital listening (the use of social media content for Market Research), the use of observational\/ethnographic approaches and work carried out online via mobile devices. Section\u00a01.3 of the EphMRA code states that \u2018Market Research (as defined above) relating to market or consumer behaviour of the sort that pharmaceutical companies routinely commission, whether involving healthcare professionals, patients, carers or members of the public does not require Clinical Research Ethics Committee or Independent Review Board approval (Institutional Review Board in the USA).\u2019 [\n                      \n                      ]. Investigational tools and procedures were reviewed and approved by the GSK Medical Governance Boards in each participating country prior to recruitment to ensure that these were fully compliant with the above conditions and any additional national codes and legislation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared the following potential conflicts of interest with respect to the research, authorship, and\/or publication of this article. The following authors are employees of GSK (J.A., D.P., M.M., C.L., M.S., and D.B-A.) and hold stocks in GSK. G.C.K.W.K. is a former employee of GSK and holds stocks in the company. The opinions expressed in this article are those of the authors and do not necessarily reflect the views of their employers or organizations. G.T. is an employee of Adelphi Research which received funding from GSK Plc for the conduct of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1717"}}